MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$128,556K
(provision for) benefit
from income taxes
$870K
Loss before income
taxes
-$127,686K
Interest income
$6,512K
Collaboration And License
$165,201K
Royalty
$79,687K
Other income
(expense)
-$934K
Non-cash interest
expense on liabilities...
$19,469K
Loss from operations
-$113,283K
Total revenues
$207,279K
Total operating
expenses
$320,562K
Selling, general and
administrative
$87,937K
Research and development
$203,280K
Cost of sales
$29,345K
Back
Back
Income Statement
source: myfinsight.com
Ultragenyx Pharmaceutical Inc. (RARE)
Ultragenyx Pharmaceutical Inc. (RARE)